[Federal Register Volume 63, Number 165 (Wednesday, August 26, 1998)] [Proposed Rules] [Page 45427] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-22813] [[Page 45427]] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 101 [Docket No. 98N-0044] RIN 0910-AA59 Regulations on Statements Made for Dietary Supplements Concerning the Effect of the Product on the Structure or Function of the Body; Extension of Comment Period
Agency
Food and Drug Administration, HHS.
Action
Proposed rule; extension of comment period.
-----------------------------------------------------------------------
Summary
The Food and Drug Administration (FDA) is extending to September 28, 1998, the comment period for the proposed rule that appeared in the Federal Register of April 29, 1998 (63 FR 23624). The document proposed regulations defining the types of statements that can be made concerning the effect of a dietary supplement on the structure or function of the body. Interested persons were given until August 27, 1998, to comment on the proposed rule. This action is being taken in response to requests for an extension of the comment period.
Dates
Written comments by September 28, 1998.
Addresses
Submit written comments to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
For Further Information Contact
Jeanne Latham, Center for Food Safety and Applied Nutrition (HFS-456), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 202-205-4697.
Supplementary Information
In the Federal Register of April 29, 1998 (63 FR 23624), FDA issued a proposed rule defining the types of statements that can be made concerning the effect of a dietary supplement on the structure or function of the body. Interested persons were given until August 27, 1998, to comment on the proposal. FDA has received several requests for an extension of the comment period. After evaluating these requests, the agency has decided to extend the comment period on the proposed rule until September 28, 1998. To be considered, written comments regarding the proposed rule must be received by September 28, 1998, by the Dockets Management Branch (address above). Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with Docket No. 98N-0044. Received comments may be seen in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.
Dated: August 20, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination. [FR Doc. 98-22813 Filed 8-25-98; 8:45 am] BILLING CODE 4160-01-F